Sign up to save your podcasts
Or
Share S1 Episode 2: How to Optimize Treatment Timing in Bladder Cancer
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
S1 Episode 2: How to Optimize Treatment Timing in Bladder Cancer
Drs Cheryl Lee and Matthew Galsky superbly synthesize the latest critical elements for sequencing perioperative bladder cancer therapies.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/970412). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Multimodal Management of Muscle Invasive Bladder Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190161/
Role of Immunotherapy in Localized Muscle Invasive Urothelial Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461126/
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795541/
View all episodes
By Medscape
5
11 ratings
Drs Cheryl Lee and Matthew Galsky superbly synthesize the latest critical elements for sequencing perioperative bladder cancer therapies.
Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/970412). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Multimodal Management of Muscle Invasive Bladder Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4190161/
Role of Immunotherapy in Localized Muscle Invasive Urothelial Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461126/
Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795541/